Gene Salkind's Net Worth

$7.08 Million

Estimate Recalculated Nov 1, 2024 05:03AM EST

Who is Gene Salkind?

Gene Salkind has an estimated net worth of $7.08 Million. This is based on reported shares across multiple companies, which include DermTech, Inc., Mobiquity Technologies, Inc., GROVE, INC., and Coeptis Therapeutics Holdings, Inc..

SEC CIK

Gene Salkind's CIK is 0001592481

Past Insider Trading and Trends

2019 was Gene Salkind's most active year for acquiring shares with 19 total transactions. Gene Salkind's most active month to acquire stocks was the month of August. 2019 was Gene Salkind's most active year for disposing of shares, totalling 2 transactions. Gene Salkind's most active month to dispose stocks was the month of July. 2019 saw Gene Salkind paying a total of $9,939,500.00 for 455,545,093 shares, this is the most they've acquired in one year. In 2019 Gene Salkind cashed out on 1,007,593 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

DermTech, Inc. (DMTK) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+3.47%
6K
—
—
179.15K
Jan 30
Form 4
+4.59%
7.59K
—
—
173.15K
Dec 31
Form 3
—
0
—
—
0
No matching records found

Mobiquity Technologies, Inc. (MOBQ) Snapshot price: $2.84

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Oct 8
Form 4/A
+1,399.21%
7.68M
$0.20
$1,535,032.00
8.22M
Aug 6
Form 4
+1,399.21%
7.68M
$0.20
$1,535,032.00
8.22M
Aug 6
Form 4
—
0
—
—
0
Jun 27
Form 4
—
0
—
—
0
Dec 15 - Dec 19
Form 4
—
0
—
—
0
Nov 7
Form 4/A
+50.25%
150K
$0.65
$97,500.00
448.54K
Oct 6
Form 4
+50.25%
150K
$0.65
$97,500.00
448.54K
Oct 6
Form 4
+44.81%
1.39M
$0.17
$235,562.71
4.48M
Apr 12
Form 4
+4.39%
130K
$0.17
$21,710.00
3.09M
Apr 6
Form 4
+15.79%
408K
$1.25
$510,000.00
2.99M
Jun 30
Form 4
+122.61%
1.37M
$1.50
$2,052,499.50
2.48M
Mar 30
Form 4
—
0
—
—
0
Dec 8
Form 4
+50.61%
375K
—
—
1.12M
Sep 30
Form 4
—
0
—
—
0
Apr 1
Form 4
+5.33%
15M
$0.01
$150,000.00
296.32M
Sep 8
Form 4
+5.63%
15M
$0.01
$150,000.00
281.32M
Jul 21
Form 4/A
+191.64%
175M
$0.02
$3,194,750.00
266.32M
Sep 13
Form 4
+191.64%
175M
$0.02
$3,194,750.00
266.32M
Sep 13
Form 4
+3.54%
3.13M
$0.08
$250,000.00
91.32M
Jul 19
Form 4
+16.51%
12.5M
$0.04
$500,000.00
88.19M
Jul 14
Form 4
+4.31%
3.13M
$0.08
$250,000.00
75.69M
Jun 18
Form 4
+10.45%
6.88M
$0.08
$550,000.00
72.66M
May 3
Form 4
+23.46%
12.5M
$0.08
$1,000,000.00
65.78M
Apr 3
Form 4
+1,522.83%
50M
$0.02
$1,000,000.00
53.28M
Jan 14
Form 3
—
0
—
—
0
No matching records found

GROVE, INC. (UPXI) Snapshot price: $0.19

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Sep 30
Form 4
∞
125K
$4.00
$500,000.00
125K
Form 4
—
0
—
—
0
Jul 21
Form 3
—
0
—
—
0
No matching records found

Coeptis Therapeutics Holdings, Inc. (COEP) Snapshot price: $0.192

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+4.26%
11.6K
$0.69
$8,004.00
284.06K
Jan 5
Form 4
+81,610.00%
32.64K
$0.96
$30,106.64
32.68K
Aug 25 - Aug 29
Form 4
—
0
—
—
0
Jan 27
Form 3
—
0
—
—
0
No matching records found